降低小儿脑肿瘤毒性的方法。

IF 2.8 4区医学 Q2 ONCOLOGY

Current oncology Pub Date : 2025-05-15 DOI:10.3390/curroncol32050281

Hallie Coltin, Christina Coleman, Chantel Cacciotti

{"title":"降低小儿脑肿瘤毒性的方法。","authors":"Hallie Coltin, Christina Coleman, Chantel Cacciotti","doi":"10.3390/curroncol32050281","DOIUrl":null,"url":null,"abstract":"Pediatric central nervous system (CNS) tumor survivors are highly susceptible to long-term toxicity due to tumor location and also the treatment received. Advancements in treatment techniques, risk-adapted approaches to therapy with adjustments to treatment regimens-including de-escalation when feasible-along with the addition of supportive therapy and surveillance in these survivors, serve to minimize and manage late effects of therapy.","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"32 5","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Approaches to Reduce Toxicity in Pediatric Brain Tumors.\",\"authors\":\"Hallie Coltin, Christina Coleman, Chantel Cacciotti\",\"doi\":\"10.3390/curroncol32050281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pediatric central nervous system (CNS) tumor survivors are highly susceptible to long-term toxicity due to tumor location and also the treatment received. Advancements in treatment techniques, risk-adapted approaches to therapy with adjustments to treatment regimens-including de-escalation when feasible-along with the addition of supportive therapy and surveillance in these survivors, serve to minimize and manage late effects of therapy.\",\"PeriodicalId\":11012,\"journal\":{\"name\":\"Current oncology\",\"volume\":\"32 5\",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/curroncol32050281\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol32050281","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

小儿中枢神经系统（CNS）肿瘤幸存者由于肿瘤的位置和所接受的治疗而极易产生长期毒性。治疗技术的进步，适应风险的治疗方法，以及对治疗方案的调整——包括在可行的情况下减少升级——以及对这些幸存者的支持治疗和监测的增加，有助于最大限度地减少和管理治疗的后期影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Approaches to Reduce Toxicity in Pediatric Brain Tumors.

Pediatric central nervous system (CNS) tumor survivors are highly susceptible to long-term toxicity due to tumor location and also the treatment received. Advancements in treatment techniques, risk-adapted approaches to therapy with adjustments to treatment regimens-including de-escalation when feasible-along with the addition of supportive therapy and surveillance in these survivors, serve to minimize and manage late effects of therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current oncology ONCOLOGY-

CiteScore

3.30

自引率

7.70%

发文量

664

审稿时长

1 months

期刊介绍： Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.